Stockwatch Daily - - HEALTH CARE -

- Acerus Phar­ma­ceu­ti­cals Corp. has ap­pointed Mark Lievo­nen to its board of di­rec­tors. Mr. Lievo­nen was most re­cently pres­i­dent of Sanofi Pas­teur Ltd. Mr. Lievo­nen re­places Tom Rossi who has quit as a di­rec­tor. (ASP) $0.36

- Arev Nutri­tion Sciences Inc. has hired Dr. Adrian Wade as project man­ager, ef­fec­tive im­me­di­ately. Arev has also formed an ad­vi­sory com­mit­tee con­sist­ing of Dr. Wade, Dr. Christina Juneau and Dr. Shab­tai Bittman. (AREV) $0.49

- ChroMedX Corp. has ap­pointed Dr. Richard Janeczko as a di­rec­tor. Dr. James Sam­soon­dar will re­sign from the board of di­rec­tors. (CHX) $0.68

- Co­hbar Inc. has ap­pointed Dr. John Ama­truda, a co-founder and sci­en­tific ad­viser of the com­pany, as a di­rec­tor. Dr. Ama­truda is cur­rently a di­rec­tor of biotech­nol­ogy firms CureDM, Pro­sciento and Fractyl. (COB) $4.76

- Fen­nec Phar­ma­ceu­ti­cals Inc. has ar­ranged an un­der­writ­ten pub­lic of­fer­ing. (FRX) $11.35

- Im­munoVac­cine Inc. and UConn Health will be­gin work­ing toward DPX-NEO’s first clin­i­cal trial. The DPX-NEO pro­gram is evaluating the anti-cancer ac­tiv­ity of pa­tient-spe­cific epi­topes de­vel­oped at UConn Health and for­mu­lated in De­poVax. (IMV) $1.91

- Lex­ing­ton Bio­sciences Inc. has hired Nav­i­gant Con­sult­ing Inc. to de­velop a cov­er­age policy for its HeartSen­try prod­uct. (LNB) $0.57

- Open Source Health Inc. has agreed to set­tle $100,000 owed to cred­i­tors by is­su­ing two mil­lion shares at five cents each. As part of the set­tle­ment, in­sider Gary Bartholomew ac­quired one mil­lion shares through a com­pany owned and con­trolled by him. (OSH) $0.03

Newspapers in English

Newspapers from Canada

© PressReader. All rights reserved.